Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
(73 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | :Co-chairs: | + | :Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE |
− | : | + | :RSNA Staff Support: Julie Lisiecki |
− | + | * [http://tinyurl.com/QIBA-CEUS-Roster Roster] | |
+ | |||
==Project Snapshot== | ==Project Snapshot== | ||
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging. | The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging. | ||
− | + | '''Project Descriptions:''' | |
− | * | + | *[[Media:Project Description CEUS QIBA final_MA.docx | Project Description / Outline of the group's planned work]] |
+ | *[[Media:QIBA CEUS project-summary table.pdf | Summary Table of Project]] | ||
+ | |||
+ | |||
+ | '''CEUS Biomarker Committee Proposal:''' | ||
+ | *[[Media:QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA CEUS Biomarker Committee Proposal]] | ||
+ | |||
+ | |||
+ | ==Recent Meetings== | ||
+ | '''Approved Call Summaries:''' | ||
+ | |||
+ | *[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]] | ||
+ | *[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]] | ||
+ | *[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]] | ||
+ | *[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]] | ||
+ | |||
− | + | '''''[[US CEUS Call Summary Archive]]''''' | |
− | + | ||
+ | [[CEUS Task Force (TF) Call Summaries]] | ||
− | |||
==Working Documents== | ==Working Documents== | ||
+ | *[[Media:QIBA CEUS Task Forces - Next Steps.docx| QIBA CEUS Task Forces - Next Steps]] | ||
− | |||
− | |||
==Statistical Reference Documents== | ==Statistical Reference Documents== | ||
− | |||
==Workflow Documents== | ==Workflow Documents== | ||
Line 32: | Line 46: | ||
==Reference Materials== | ==Reference Materials== | ||
− | Original Proposal to the QIBA Steering Committee | + | Original Proposal to the QIBA Steering Committee: |
*[[Media: QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA Committee for Quantitative Contrast Enhanced Ultrasound Proposal]] | *[[Media: QIBA Committee for Quantitative Contrast Enhanced Ultrasound_Final.pdf | QIBA Committee for Quantitative Contrast Enhanced Ultrasound Proposal]] | ||
− | Vendor Press Release | + | Vendor Press Release: |
*[[Media:US-20160404-PR_221236_LUMASON_Liver-PR_0.pdf|FDA Approval for LUMASON® Press Release]] | *[[Media:US-20160404-PR_221236_LUMASON_Liver-PR_0.pdf|FDA Approval for LUMASON® Press Release]] | ||
+ | Presentations: | ||
*[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]] | *[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Hoyt Presentation]] | ||
+ | *[[Media: QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin.pdf|QIBA Ultrasound Biomarkers Meeting, 03.29.2012-Dr. Rognin Presentation]] |
Revision as of 15:39, 6 May 2022
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: